NOVO NORDISK FILES FOR FDA APPROVAL OF CAGRISEMA, THE FIRST ONCE-WEEKLY COMBINATION OF GLP‑1 AND AMYLIN ANALOGUES FOR WEIGHT MANAGEMENT

Reuters · 1d ago

Please log in to view news